Publication | Closed Access

Engineered PD-1/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T cell/Treg balance and alleviate systemic lupus erythematosus

NanomedicineTherapeutic NanomaterialsImmunologyNano-drug DeliveryImmunotherapyMedicineCell BiologySynthetic ImmunologyDexamethasone Act